Panel Discussion: Streamlining the Design & Implementation of Co-Development Plans to Shape Therapeutic Effectiveness

Time: 2:40 pm
day: Day 2 Track C PM

Details:

Moderator: Joseph Ferarra, Chief Strategy Officer, Veranex

  • Highlighting current challenges and on going efforts to address drug-DX development
  • Exploring the regulatory challenges of using multiple CDx from patient perspectives
  • Assessing the impact of co-development on patient trial design

Speakers: